LHR
Lunate Holding RSC Portfolio holdings
AUM
$211M
This Quarter Return
-3.88%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$211M
AUM Growth
–
Cap. Flow
+$211M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$96.1M |
| 2 |
Birkenstock
BIRK
|
$57.2M |
| 3 |
LINE
Lineage, Inc. Common Stock
LINE
|
$35.1M |
| 4 |
Neumora Therapeutics
NMRA
|
$22.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 56.21% |
| 2 | Consumer Discretionary | 27.13% |
| 3 | Real Estate | 16.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.1B
| $96.1M | 45.54% |
+2,196,200
| New | +$96.1M |
|
|
2
Birkenstock
BIRK
$9.59B
| $57.2M | 27.13% |
+1,010,000
| New | +$57.2M |
|
|
LINE
3
Lineage, Inc. Common Stock
LINE
$9.59B
| $35.1M | 16.66% |
+600,000
| New | +$35.1M |
|
|
4
Neumora Therapeutics
NMRA
$280M
| $22.5M | 10.67% |
+2,124,143
| New | +$22.5M |
|